Dermapharm Holding SE (DMP) — Free Cash Flow Generation Index
Dermapharm Holding SE (DMP) has a Free Cash Flow Generation Index of 0.87x as of December 2025. Free cash flow of €80.52 Million represents 1% of operating cash flow (€92.40 Million). See Dermapharm Holding SE short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dermapharm Holding SE Free Cash Flow Generation Index (2014–2025)
Historical FCF Generation Index trend for Dermapharm Holding SE across 12 annual periods. Explore DMP operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Dermapharm Holding SE (2014–2025)
Year-by-year Free Cash Flow Generation Index for Dermapharm Holding SE. For the full company profile including market capitalisation, see how much is Dermapharm Holding SE worth.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.77x | €139.39 Million | €181.51 Million | €42.12 Million | ▼ -5.2% |
| 2024 | 0.81x | €163.14 Million | €201.38 Million | €38.24 Million | ▼ -0.1% |
| 2023 | 0.81x | €177.88 Million | €219.42 Million | €41.54 Million | ▼ -6.3% |
| 2022 | 0.86x | €249.52 Million | €288.53 Million | €39.01 Million | ▲ +14.5% |
| 2021 | 0.76x | €189.16 Million | €250.37 Million | €61.20 Million | ▲ +9.7% |
| 2020 | 0.69x | €90.30 Million | €131.10 Million | €40.80 Million | ▲ +27.9% |
| 2019 | 0.54x | €54.17 Million | €100.61 Million | €46.44 Million | ▼ -35.7% |
| 2018 | 0.84x | €133.16 Million | €159.13 Million | €25.97 Million | ▲ +503.8% |
| 2017 | 0.14x | €12.02 Million | €86.74 Million | €74.72 Million | ▼ -82.0% |
| 2016 | 0.77x | €59.02 Million | €76.78 Million | €17.76 Million | ▲ +22.0% |
| 2015 | 0.63x | €25.44 Million | €40.38 Million | €14.93 Million | ▲ +32.4% |
| 2014 | 0.48x | €25.83 Million | €54.26 Million | €28.42 Million | — |